Practice Areas - Corporate and M&A Law Firms and Lawyers
Deal Date: | 01-10-2014 | Practice Area: | Corporate and M&A |
Deal Title: | Johnson and Johnson Acquisition of Alios BioPharma | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Alios BioPharma, Inc., a biotechnology company developing proprietary therapeutics for viral diseases, has announced a definitive agreement with Johnson and Johnson whereby Alios was acquired for approximately USD1.75 billion in cash payable upon closing of the transaction.
Latham and Watkins LLP represented Alios BioPharma in the transaction with a corporate team led from the firm's Silicon Valley office by partner Mark Roeder and associate Chad Rolston.
|
||
Financial Center: | Silicon Valley | Value: | 1000.01-5000.00 |
Advised Party: | Target Company | Law Firm | Latham & Watkins |
Target Company Jurisdiction: | United States | Acquiror Jurisdiction: | United States |
Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | Mark V Roeder |